EAM

Exome Asset Management Portfolio holdings

AUM $151M
1-Year Est. Return 46.2%
This Quarter Est. Return
1 Year Est. Return
+46.2%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$151M
AUM Growth
+$41.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
85
New
Increased
Reduced
Closed

Top Buys

1
+$5.44M
2
+$4.27M
3
+$3.75M
4
ARWR icon
Arrowhead Research
ARWR
+$3.6M
5
CVS icon
CVS Health
CVS
+$3.29M

Top Sells

1
+$3.18M
2
+$2.99M
3
+$2.93M
4
VSTM icon
Verastem
VSTM
+$2.49M
5
GERN icon
Geron
GERN
+$2.13M

Sector Composition

1 Healthcare 97.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IONS icon
1
Ionis Pharmaceuticals
IONS
$13.2B
$8.57M 5.19%
131,016
+9,900
CYTK icon
2
Cytokinetics
CYTK
$8.03B
$7.83M 4.74%
142,417
+26,600
BBIO icon
3
BridgeBio Pharma
BBIO
$14.2B
$6.91M 4.19%
133,087
-22,446
COGT icon
4
Cogent Biosciences
COGT
$5.95B
$6.37M 3.86%
443,547
-90,100
GH icon
5
Guardant Health
GH
$13.2B
$6.13M 3.71%
98,182
LLY icon
6
Eli Lilly
LLY
$904B
$5.99M 3.63%
7,852
+3,179
NBP
7
NovaBridge Biosciences American Depositary Shares
NBP
$482M
$5.44M 3.3%
+1,439,604
PRAX icon
8
Praxis Precision Medicines
PRAX
$6.2B
$5.41M 3.27%
101,996
+42,994
VERA icon
9
Vera Therapeutics
VERA
$2.87B
$4.54M 2.75%
156,072
+79,372
AZN icon
10
AstraZeneca
AZN
$280B
$4.27M 2.59%
+28,362
IRON icon
11
Disc Medicine
IRON
$3.52B
$4.05M 2.46%
61,356
ETNB
12
DELISTED
89bio
ETNB
$4.02M 2.44%
273,661
+40,235
APGE icon
13
Apogee Therapeutics
APGE
$5.24B
$3.75M 2.27%
+94,400
TVTX icon
14
Travere Therapeutics
TVTX
$3.13B
$3.75M 2.27%
156,917
+3,639
THC icon
15
Tenet Healthcare
THC
$18.5B
$3.68M 2.23%
18,100
-8,900
ARWR icon
16
Arrowhead Research
ARWR
$8.34B
$3.6M 2.18%
+104,507
CVS icon
17
CVS Health
CVS
$96B
$3.29M 1.99%
+43,600
SLNO icon
18
Soleno Therapeutics
SLNO
$2.76B
$3.27M 1.98%
48,445
+6,804
NTRA icon
19
Natera
NTRA
$33.8B
$3M 1.82%
18,650
CRBP icon
20
Corbus Pharmaceuticals
CRBP
$180M
$2.91M 1.76%
229,962
-47,355
ISRG icon
21
Intuitive Surgical
ISRG
$204B
$2.84M 1.72%
6,358
EWTX icon
22
Edgewise Therapeutics
EWTX
$2.5B
$2.81M 1.7%
173,439
+48,969
UTHR icon
23
United Therapeutics
UTHR
$21.1B
$2.79M 1.69%
+6,645
AKRO icon
24
Akero Therapeutics
AKRO
$4.49B
$2.78M 1.68%
+58,579
IMVT icon
25
Immunovant
IMVT
$4B
$2.56M 1.55%
+158,622
1
2 3 4